Founded in 1991 in Newport, Adesis recently purchased its New Castle building in May to expand its custom organic synthesis, research & development, and specialty manufacturing capabilities.
The New Castle facility is a 47,500-square-foot building in the Southgate Industrial Center, of which Adesis had previously leased about 25,100 square feet.
“We are very pleased to have the opportunity to host Senator Tom Carper at our facility and showcase the latest developments at Adesis,” said Andrew Cottone, president of Adesis, Inc. “As a leading organic synthesis CRO (contract research organization), we are broadening our presence in Delaware and appreciate Senator Carper’s long-standing support of businesses and new career opportunities. The recent purchase of our building will allow us to expand our critical mass, increase our headcount, and further grow our custom molecular synthesis, research, development, and specialty manufacturing business across the pharmaceutical, chemical, biomaterials, and catalysts industries.”
Adesis, Inc. is a contract research organization (CRO) supporting the pharma, biotech, catalysis and a number of other industries.
Adesis has a business model of providing clients with organic chemistry services in three areas: early stage research, scale up and development, and specialty manufacturing. The company has more than 50 chemists.
Adesis can also act as a specialty manufacturer to reinforce supply chains. To learn more about Adesis, please visit http://adesisinc.com/